AGEN
#3166
Agenus Inc. - Common Stock
8.0 9 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.25%
Variación mensual
+5.75%
Variación en los últimos 6 meses
+148.16%
Cambio anual
+89.02%
Cierres anteriores
7.9 9
Open
8.0 1
Mínimo
7.9 5
Máximo
8.1 3
Volumen
298
Financials
- Market Capitalization 364.22 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
1.01
Relación precio/flujo de caja
0.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3151 |  IRD Opus Genetics, Inc. - Common Stock | 4.47 USD | +16.71% | +17.63% | +20.16% | +20.16% | 371.89 M USD | ||
| 3152 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.96 USD | +2.96% | +1.08% | +14.64% | -38.16% | 366.60 M USD | ||
| 3181 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.51 USD | +5.46% | +0.80% | +14.61% | +43.43% | 350.24 M USD | ||
| 3197 |  PALI Palisade Bio, Inc. - Common Stock | 2.00 USD | +2.04% | -6.10% | +5.26% | +17.65% | 348.54 M USD |